CN100339067C - 一种药物新剂型-纳米乳剂型的制备方法 - Google Patents
一种药物新剂型-纳米乳剂型的制备方法 Download PDFInfo
- Publication number
- CN100339067C CN100339067C CNB031417388A CN03141738A CN100339067C CN 100339067 C CN100339067 C CN 100339067C CN B031417388 A CNB031417388 A CN B031417388A CN 03141738 A CN03141738 A CN 03141738A CN 100339067 C CN100339067 C CN 100339067C
- Authority
- CN
- China
- Prior art keywords
- emulsion
- preparation
- oil
- dosage form
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 20
- 238000004945 emulsification Methods 0.000 title claims description 7
- 239000003814 drug Substances 0.000 claims abstract description 23
- 239000012071 phase Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002552 dosage form Substances 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 239000006184 cosolvent Substances 0.000 claims abstract description 6
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 5
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 5
- 239000008346 aqueous phase Substances 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000012856 packing Methods 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 4
- 239000007908 nanoemulsion Substances 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 16
- -1 fatty acid ester Chemical class 0.000 claims description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 229920002545 silicone oil Polymers 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 4
- 235000006708 antioxidants Nutrition 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229960001631 carbomer Drugs 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000003925 fat Substances 0.000 claims description 4
- 235000019197 fats Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- 238000004137 mechanical activation Methods 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 235000019737 Animal fat Nutrition 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- ZJJGPUQRMUBVBE-UHFFFAOYSA-N C(CCC)OC(=O)C1=CC=C(O)C=C1.[Ca] Chemical compound C(CCC)OC(=O)C1=CC=C(O)C=C1.[Ca] ZJJGPUQRMUBVBE-UHFFFAOYSA-N 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 2
- KWKVAGQCDSHWFK-VNKDHWASSA-N Methyl sorbate Chemical compound COC(=O)\C=C\C=C\C KWKVAGQCDSHWFK-VNKDHWASSA-N 0.000 claims description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 229960002449 glycine Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 235000002949 phytic acid Nutrition 0.000 claims description 2
- 239000000467 phytic acid Substances 0.000 claims description 2
- 229940068041 phytic acid Drugs 0.000 claims description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 claims description 2
- 229940043349 potassium metabisulfite Drugs 0.000 claims description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 2
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 2
- 229960005055 sodium ascorbate Drugs 0.000 claims description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 2
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 claims description 2
- IXMINYBUNCWGER-UHFFFAOYSA-M sodium;4-propoxycarbonylphenolate Chemical compound [Na+].CCCOC(=O)C1=CC=C([O-])C=C1 IXMINYBUNCWGER-UHFFFAOYSA-M 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 2
- 239000009969 fructus bruceae Substances 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 241000158621 Brucea Species 0.000 description 1
- 206010022086 Injection site pain Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000004064 cosurfactant Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031417388A CN100339067C (zh) | 2003-07-22 | 2003-07-22 | 一种药物新剂型-纳米乳剂型的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031417388A CN100339067C (zh) | 2003-07-22 | 2003-07-22 | 一种药物新剂型-纳米乳剂型的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1568938A CN1568938A (zh) | 2005-01-26 |
CN100339067C true CN100339067C (zh) | 2007-09-26 |
Family
ID=34471039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031417388A Expired - Lifetime CN100339067C (zh) | 2003-07-22 | 2003-07-22 | 一种药物新剂型-纳米乳剂型的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100339067C (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5096138B2 (ja) * | 2005-03-31 | 2012-12-12 | サントリーホールディングス株式会社 | リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物 |
CN1771911B (zh) * | 2005-11-10 | 2010-05-12 | 浙江大学 | 一种可再分散的难溶性药物纳米粒粉末及制备方法 |
CN101879138A (zh) * | 2009-05-06 | 2010-11-10 | 上海恒瑞医药有限公司 | 长春花生物碱纳米乳剂注射液及其制备方法 |
CN101797259B (zh) * | 2010-03-15 | 2013-05-01 | 陈鹏举 | 一种复方维生素纳米乳 |
CN102166270A (zh) * | 2011-04-06 | 2011-08-31 | 西北农林科技大学 | 一种水包油型陈皮油纳米乳及其制备方法 |
CN102415996B (zh) * | 2011-12-13 | 2013-06-05 | 齐鲁动物保健品有限公司 | 兽用盐酸沃尼妙林自乳化口服纳米乳制剂及其制备方法 |
CN104856951A (zh) * | 2015-05-06 | 2015-08-26 | 华侨大学 | 一种卵泡刺激素透皮纳米乳剂及其制备方法 |
CN106361758B (zh) * | 2016-08-31 | 2019-02-12 | 甘肃新天马制药股份有限公司 | 一种复方伊维菌素吡喹酮双连续相乳剂及其制备方法 |
CN108013029A (zh) * | 2017-12-29 | 2018-05-11 | 咸阳职业技术学院 | 一种复合酚纳米乳剂及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1196928A (zh) * | 1997-03-18 | 1998-10-28 | 莱雅公司 | 以非离子两亲类脂和胺化硅氧烷为主要成分的毫微乳化液及其应用 |
CN1232830A (zh) * | 1998-03-20 | 1999-10-27 | 陶氏康宁公司 | 盐稳定阳离子硅氧烷水包油微乳液 |
CN1253018A (zh) * | 1998-11-03 | 2000-05-17 | 中国医学科学院生物医学工程研究所 | 胰岛素纳米粒子及制备方法 |
CN1286081A (zh) * | 2000-08-29 | 2001-03-07 | 上海维来现代科技发展有限公司 | 注射用高浓度超细全氟碳乳液及其制备方法 |
US6537561B1 (en) * | 1997-02-27 | 2003-03-25 | Nippon Shinyaku Co., Ltd. | Fat emulsion for oral administration |
-
2003
- 2003-07-22 CN CNB031417388A patent/CN100339067C/zh not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537561B1 (en) * | 1997-02-27 | 2003-03-25 | Nippon Shinyaku Co., Ltd. | Fat emulsion for oral administration |
CN1196928A (zh) * | 1997-03-18 | 1998-10-28 | 莱雅公司 | 以非离子两亲类脂和胺化硅氧烷为主要成分的毫微乳化液及其应用 |
CN1232830A (zh) * | 1998-03-20 | 1999-10-27 | 陶氏康宁公司 | 盐稳定阳离子硅氧烷水包油微乳液 |
CN1253018A (zh) * | 1998-11-03 | 2000-05-17 | 中国医学科学院生物医学工程研究所 | 胰岛素纳米粒子及制备方法 |
CN1286081A (zh) * | 2000-08-29 | 2001-03-07 | 上海维来现代科技发展有限公司 | 注射用高浓度超细全氟碳乳液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
微乳在药剂学上的应用 王晓黎等,解放军药学学报,第16卷第2期 2000 * |
Also Published As
Publication number | Publication date |
---|---|
CN1568938A (zh) | 2005-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1160122C (zh) | 一种制备口服胰岛素油相制剂的方法 | |
CN100509054C (zh) | 使用磷脂酰胆碱的局部给药 | |
DE69525761T2 (de) | MITTEL MIT GESTEUERTER FREISETZUNG, DIE EINE UMGEKEHRTE MICELLARE (L2) STRUKTUR ODER EINE NORMALE MICELLARE (l1) STRUKTUR BILDEN | |
DE69820973T2 (de) | Biphasige arzneimitteldosierungsform aus vielen komponenten, die stoffe enthält, die die verteilung der arzneimittel beeinflussen können | |
EP1305006B1 (de) | Verfahren zur herstellung von dispersionen zur formulierung wenig oder schwer löslicher wirkstoffe | |
CN101708314B (zh) | 一种中药挥发油注射溶液及其注射剂和制备方法 | |
CN1332648C (zh) | 微乳预浓缩物 | |
CN100569294C (zh) | 一种静脉注射用高稳定长循环脂肪乳载药制剂 | |
CN101019833B (zh) | 一种用作药物载体的药用油包油型非水微乳及其药物制剂 | |
KR100810164B1 (ko) | 이데베논 나노캡슐을 함유하는 주름개선 화장료 조성물 및이의 제조방법 | |
CN104427976B (zh) | 疏水的活性成分的储库制剂及其制备方法 | |
CN102327199B (zh) | 包含具有双壳结构的纳米结构体的化妆品成分 | |
EP2298282B1 (en) | Combination of drugs having different physical properties into single dosage form | |
WO2010139278A1 (zh) | 制备载药乳剂的方法 | |
DE69119400T2 (de) | System auf basis einer lipidformulierung | |
CN100339067C (zh) | 一种药物新剂型-纳米乳剂型的制备方法 | |
KR100785484B1 (ko) | 고농도의 이데베논을 나노캡슐화한 기제 조성물, 이의제조방법 및 이를 함유한 화장료 | |
Hussein et al. | Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier | |
WO1990014073A1 (de) | Pharmazeutische zubereitung | |
CN110772482A (zh) | 一种高比例乳化剂的乳剂及其制备方法 | |
EP3568123B1 (de) | Einbringen von schwer und/oder nicht wasserlöslichen wirkstoffen mittels auf lipiden basierenden nanopartikeln/vesikeln in ein hydrophiles aus cellulose bestehendes dreidimensionales netzwerk | |
CN106619588A (zh) | 一种含辅酶q10的自微乳型营养组合物、制备方法及用途 | |
KR101507884B1 (ko) | 온도감응성 고분자 지질을 이용하여 친수성 활성물질을 함유한 나노캡슐 농축조성물, 그의 제조방법 및 그를 함유한 화장료 조성물 | |
CN101433533A (zh) | 一种紫杉醇或多烯紫杉醇的静脉注射乳剂 | |
EP4232004A1 (fr) | Formulations fractales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN POLY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: FAN MINHUA Effective date: 20100707 Owner name: ZHEJIANG RUIDA PHARMACEUTICAL CO., LTD. HANGZHOU S |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310004 HOUSE 5, BUILDING 9, NO.167, HUANCHENG NORTH ROAD, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 571127 GUILINYANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, MEILAN DISTRICT, HAIKOU CITY, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100707 Address after: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Co-patentee after: Zhejiang Ruida Pharmaceutical Co.,Ltd. Patentee after: Hainan Poly Pharm Co.,Ltd. Co-patentee after: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. Address before: 5, No. 9, building 167, building 310004, Ring North Road, Hangzhou, Zhejiang Patentee before: Fan Minhua |
|
CI01 | Publication of corrected invention patent application |
Correction item: Patentee Correct: Zhejiang Ruida Pharm Co.,Ltd. False: Zhejiang Ruida Pharmaceutical Co.,Ltd. Number: 33 Volume: 26 |
|
CI03 | Correction of invention patent |
Correction item: Patentee Correct: Zhejiang Ruida Pharm Co.,Ltd. False: Zhejiang Ruida Pharmaceutical Co.,Ltd. Number: 33 Page: The title page Volume: 26 |
|
C56 | Change in the name or address of the patentee |
Owner name: HAINAN PLOY PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HAINAN PULIN PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Patentee after: HAINAN POLY PHARM. Co.,Ltd. Patentee after: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Patentee after: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. Address before: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Patentee before: Hainan Poly Pharm Co.,Ltd. Patentee before: Zhejiang Ruida Pharm Co.,Ltd. Patentee before: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Zhu Xulei Document name: It is deemed that no notice has been given |
|
DD01 | Delivery of document by public notice | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20070926 |